TY  - GEN
AU  - Martín-Montañez, Elisa
AU  - Valverde, Nadia
AU  - Ladrón de Guevara-Miranda, David
AU  - Lara, Estrella
AU  - Romero-Zerbo, Yanina S.
AU  - Millon, Carmelo
AU  - Boraldi, Federica
AU  - Ávila-Gámiz, Fabiola
AU  - Pérez-Cano, Ana M.
AU  - Garrido-Gil, Pablo
AU  - Labandeira-Garcia, Jose Luis
AU  - Santin, Luis J.
AU  - Pavia, Jose
AU  - Garcia-Fernandez, Maria
PY  - 2021
DO  - 10.1016/j.redox.2021.102095
UR  - http://hdl.handle.net/20.500.12105/18423
AB  - Oxidative distress and mitochondrial dysfunction, are key factors involved in the pathophysiology of Parkinson's disease (PD). The pleiotropic hormone insulin-like growth factor II (IGF-II) has shown neuroprotective and antioxidant effects in some...
LA  - eng
PB  - Elsevier
KW  - Insulin like growth factor-II
KW  - Neuroprotection
KW  - Mitochondria
KW  - Oxidative distress
KW  - Parkinson’s disease
KW  - 1-methyl-4-phenylpyridinium
KW  - Dopaminergic neurons
KW  - Factor II del crecimiento similar a la insulina
KW  - Neuroprotección
KW  - Mitocondrias
KW  - Estrés oxidativo
KW  - Enfermedad de Parkinson
KW  - 1-metil-4-fenilpiridinio
KW  - Neuronas dopaminérgicas
KW  - 1-Methyl-4-phenylpyridinium
KW  - Animals
KW  - Dopaminergic Neurons
KW  - Insulin-Like Growth Factor II
KW  - Mice
KW  - Oxidative Stress
KW  - Parkinson Disease
KW  - Neuroprotective Agents
KW  - NF-E2-Related Factor 2
KW  - Antioxidants
KW  - Receptor, IGF Type 2
KW  - Neurodegenerative Diseases
KW  - Up-Regulation
KW  - Mitochondria
KW  - TOR Serine-Threonine Kinases
KW  - Cell Culture Techniques
KW  - Hormones
TI  - Insulin-like growth factor II prevents oxidative and neuronal damage in cellular and mice models of Parkinson's disease
TY  - research article
ER  -